Published in N Engl J Med on December 24, 1998
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. J Gastroenterol (2006) 1.62
Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 1.41
Helicobacter pylori and nonulcer dyspepsia. N Engl J Med (1998) 1.40
Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol (2006) 1.21
Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil (2012) 1.14
Drug treatment of functional dyspepsia. World J Gastroenterol (2006) 1.11
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials (2012) 1.10
Are dyspeptic symptoms linked to Helicobacter pylori? A prospective cohort study among medical students. Wien Klin Wochenschr (2003) 1.08
Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease? J Neurogastroenterol Motil (2011) 1.00
Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia. J Gastroenterol (2012) 0.99
cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol (2001) 0.98
Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol (2008) 0.97
Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut (2002) 0.97
Long-term follow-up study of gastric emptying and Helicobacter pylori eradication among patients with functional dyspepsia. Dig Dis Sci (2000) 0.94
Dyspepsia: management guidelines for the millennium. Gut (2002) 0.93
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. BMC Gastroenterol (2001) 0.91
Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. West J Med (2002) 0.90
Delayed gastric emptying in patients with abnormal gastroesophageal reflux. Ann Surg (2001) 0.88
Shift work increases the frequency of duodenal ulcer in H pylori infected workers. Occup Environ Med (2006) 0.88
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterol (2012) 0.87
Functional (Nonulcer) Dyspepsia. Curr Treat Options Gastroenterol (2002) 0.86
Treatment of functional dyspepsia: where to go and what to do. J Gastroenterol (2006) 0.86
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat? Can Fam Physician (1999) 0.86
Assessment of outcome in dyspepsia: has progress been made? Gut (2002) 0.85
Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses. BMJ (1999) 0.85
Evaluation and treatment of dyspepsia. Postgrad Med J (2003) 0.85
Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. Dig Dis Sci (2001) 0.85
Proton pump inhibitors: effective first-line treatment for management of dyspepsia. Dig Dis Sci (2007) 0.84
Evaluation of thermal water in patients with functional dyspepsia and irritable bowel syndrome accompanying constipation. World J Gastroenterol (2006) 0.83
Relationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients. World J Gastroenterol (2005) 0.83
Helicobacter pylori and functional dyspepsia: review of previous studies and commentary on new data. Gut (2002) 0.83
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. Antimicrob Agents Chemother (2000) 0.83
Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis. BMC Gastroenterol (2011) 0.82
Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis. ScientificWorldJournal (2014) 0.82
Helicobacter pylori and functional dyspepsia: an unsolved issue? World J Gastroenterol (2014) 0.81
Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey. Dig Dis Sci (2005) 0.81
Comparison between empirical prokinetics, Helicobacter test-and-treat and empirical endoscopy in primary-care patients presenting with dyspepsia: a one-year study. World J Gastroenterol (2006) 0.81
Chronic gastritis is not associated with gastric dysrhythmia or delayed solid emptying in children with dyspepsia. Dig Dis Sci (2005) 0.80
Treatment of Helicobacter pylori. World J Gastroenterol (2001) 0.80
Dyspepsia in African-American and Hispanic patients. J Natl Med Assoc (2004) 0.79
Effect of Helicobacter pylori eradication in Iranian patients with functional dyspepsia: a prospective, randomized, placebo-controlled trial. Arch Med Sci (2015) 0.79
Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research. J Gastroenterol (2002) 0.78
Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study. Int J Clin Exp Med (2013) 0.78
Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. Saudi J Gastroenterol (2008) 0.78
A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgrad Med J (2002) 0.78
H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci (2001) 0.78
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test. Dig Dis Sci (2002) 0.78
How should Helicobacter pylori positive dyspeptic patients be managed? Gut (1999) 0.77
Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis. World J Gastroenterol (2016) 0.77
Helicobacter Pylori. Curr Treat Options Gastroenterol (1999) 0.76
Does Helicobacter pylori gastritis affect motor function of proximal stomach in dyspeptic patients? Dig Dis Sci (2001) 0.76
Helicobacter pylori and nonulcer dyspepsia. N Engl J Med (1999) 0.75
Helicobacter pylori and nonulcer dyspepsia. N Engl J Med (1999) 0.75
Eradicating Helicobacter pylori in non-ulcer dyspepsia may not be cost effective. BMJ (2001) 0.75
Management of uninvestigated dyspepsia: review and commentary. Gut (2002) 0.75
Helicobacter pylori and nonulcer dyspepsia. N Engl J Med (1999) 0.75
The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary. Epidemiol Infect (2015) 0.75
Helicobacter pylori in immigrants from East Africa. J Gen Intern Med (1999) 0.75
Helicobacter pylori infection. BMJ Clin Evid (2009) 0.75
Testing for Helicobacter pylori in dyspeptic patients. Did paper have statistical discrepancies? BMJ (2001) 0.75
Treatment of Helicobacter pylori infection. Development of resistance to antibiotics used must be avoided. BMJ (2000) 0.75
Eradication of Helicobacter pylori infection in non-ulcer dyspepsia. Commentary did not inform or update general medical community. BMJ (2000) 0.75
Helicobacter pylori and nonulcer dyspepsia. N Engl J Med (1999) 0.75
Is Helicobacter pylori Associated Functional Dyspepsia Correlated With Dysbiosis? J Neurogastroenterol Motil (2017) 0.75
Pretreatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with nonulcer dyspepsia. Dig Dis Sci (2001) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst (1997) 3.30
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) (1984) 3.05
The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol (1998) 3.04
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (1997) 3.02
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg (1996) 2.69
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
[Meta-analyses are hardly suitable for conclusively proving medical controversies]. Z Gastroenterol (1996) 2.47
Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44
Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut (1999) 2.43
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy (2004) 2.07
The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05
Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol (2000) 2.03
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol (1997) 2.02
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol (2000) 2.01
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology (2008) 1.97
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy (2007) 1.94
Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc (2000) 1.94
Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol (2001) 1.93
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 1.93
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology (1998) 1.92
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84
Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84
Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch (2003) 1.82
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial. Aliment Pharmacol Ther (1999) 1.80
Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch (1998) 1.79
["A sick public health services watches over health status": how the former Federal Public Health Office turned German medicine exemplified by "omeprazole and blindness" into an international joke]. Leber Magen Darm (1994) 1.78
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology (2000) 1.76
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology (1997) 1.75
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol (2006) 1.75
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
Oesophageal dysmotility is not associated with poor outcome after laparoscopic Nissen fundoplication. Br J Surg (1998) 1.73
Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol (1994) 1.73